Fig. 3From: Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinomaClassification of RGR into three subgroups; no or slow growth (RGR < 0.2%), average growth (0.2 - 0.6%) and fast growth (> 0.6%)Back to article page